Genomic imbalances in the progression of endocrine pancreatic tumors
Authors:
- 10 October 2001
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 32 (4) , 364-372
Abstract
Endocrine pancreatic tumors (EPTs) are neoplasms with malignant potential. To explore the molecular basis of metastatic progression in human EPTs, we analyzed 17 paired specimens of primary EPTs and their metastases and 28 nonmetastatic EPTs using comparative genomic hybridization (CGH). Genomic alterations were detected in all of the matched primary/metastatic tumors and 19 (58%) nonmetastatic EPTs. The mean number of genomic changes was 17.3 in metastases, 12.5 in their primary tumors, and 4.5 in nonmetastatic EPTs. Statistical analysis of shared genomic changes in matched pairs of primary tumors and metastases showed a high probability (>95%) of a clonal relationship in 15 of the 17 cases. A closely related genetic pattern was also demonstrated on the basis of concordance analysis of the two groups. The most striking genomic changes which were enriched in metastases included gains of chromosomes 4 and 7 and losses of 21q. Other common regions of frequent losses (>40%) identified in metastases and/or their primary tumors involved 2p, 2q, 3p, 3q, 6q, 10p, and 11p, whereas frequently detected gains (>40%) in the paired tumors involved 5p, 5q, 12q, 14q, 17q, 18q, and 20q. These chromosomal aberrations were found in significantly fewer nonmetastatic EPTs. Some of these chromosomal loci may harbor genes contributing to the progression of EPT.Keywords
Funding Information
- Swiss Cancer League (SKL-649-2-1998)
- Swiss National Science Foundation (31-53625.98)
This publication has 22 references indexed in Scilit:
- Genetic Differences in Endocrine Pancreatic Tumor Subtypes Detected by Comparative Genomic HybridizationThe American Journal of Pathology, 1999
- Evaluation of the Clonal Relationship between Primary and Metastatic Renal Cell Carcinoma by Comparative Genomic HybridizationThe American Journal of Pathology, 1999
- Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumorsOncogene, 1999
- Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut NeoplasmsThe American Journal of Pathology, 1999
- Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1Journal of Internal Medicine, 1998
- Determinants of metastatic rate and survival in patients with zollinger-ellison syndrome: A prospective long-term studyGastroenterology, 1995
- Gastrinomas Demonstrate Amplification of the HER-2/neu Proto-oncogeneAnnals of Surgery, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Current approach to the management of tumoral process in patients with gastrinomaWorld Journal of Surgery, 1986
- Benign and malignant gastrinomaThe American Journal of Surgery, 1985